![Norman Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 157 748 $ al 31/07/2026
Norman C.
W.
Wong was the founder of Resverlogix Corp., founded in 2000, and served as Chief Scientific Officer from 2009 to 2022.
Dr. Wong is currently a Professor at the University of Calgary, a position held since 1987.
Formerly, Dr. Wong was an Independent Director at Zenith Capital Corp.
(Alberta) from 2015 to 2026.
Dr. Wong completed undergraduate, graduate, and doctorate degrees at the University of Calgary.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZENITH CAPITAL CORP. 1,98 % | 30/01/2026 | 3.154.959 ( 1,98 % ) | 157 748 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 16/02/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
| ZENITH CAPITAL CORP. | Director/Miembro de la Junta | 03/03/2026 |
| RESVERLOGIX CORP. | Fundador | 15/08/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Resverlogix Corp.
 Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Zenith Capital Corp. (Alberta)
 Zenith Capital Corp. (Alberta) BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
University of Calgary
University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
